시스템오류접수 홈으로 연구실관리 Login 고려대학교 의과대학 홈

The Safety Security Management System is designed to be regularly updated to the latest information by linking with the following computer system to improve the accuracy and effectiveness of information.
- Academic Affair System: Info. on the persons engaged in research activities
- Space management system: Laboratory info., full-time persons who engage in research activities, information on the equipment to manage

The Lock function should be set not to automatically update the laboratory information or information on the equipment to manage.

Safety Management Guide

  • Safety in Laboratory
  • Electrical Safety
  • Fire Safety
  • Chemical Safety
  • Biosafety
  • Gas Safety
  • Waste Disposal
  • Machine/Instrument
  • Radiation Safety
Concept and Principle of Biosafety
  • Biosafety

    Biosafety indicates a series of actions to properly use biological knowledge and experimental technique, equipment, and facilities to protect laboratory researchers, laboratories, and surrounding environments from potential infectious organisms or biohazards.

  • Basic element of biosafety

    The basic elements of biosafety to prevent or minimize biohazards are proper physical containment, risk assessment capability of researchers or research organizations, and risk management operation for safety management.

Biological Safety Level (BSL)
  • Proper biosafety management such as laboratory biosafety instruction, equipment, and containment by classifying microorganisms into four risk groups in terms of pathogenicity, infectivity, and risk
       and setting the biosafety level of the laboratory with four levels.
  • Definition of the microorganism risk group
    Category Definition Microorganism
    Risk Group 1 An organism that is unlikely to cause disease in healthy adult humans. E. coli
    Risk Group 2 A microorganism that can cause disease but is unlikely to be a serious hazard to people. Effective treatment and preventive measures are easily available Vibrio cholerae
    Enteropathogenic E. coli
    Hepatitis virus
    Measles virus
    Risk Group 3 A microorganism that usually causes disease and is likely to be a serious or fatal hazard to people. Effective treatment and preventive measures are available Bacillus anthracis
    Brucella abortus
    Yersinia pestis
    SARS virus
    Yellow fever virus
    Risk Group 4 A pathogen that usually causes disease and is a very serious or fatal hazard to people. Effective treatment and preventive measures are not usually available Ebola virus
    Marburg virus
    Lassa virus
    Hendra-like virus
    • See Guidelines for Laboratory Biosafety of the National Institute of Health of the Korea Centers for Disease Control & Prevention
Safety Management of Living Modified Organisms (LMO)
  • In preparation for the ratification of the protocol, Korea enacted and promulgated the “TRANSBOUNDARY MOVEMENT, ETC. OF LIVING MODIFIED ORGANISMS ACT (in short, LMO Act)” in March 2001.
       After the ratification of the protocol in October 2007, the LMO Law started to be enforced from January 1, 2008.
LMO for Test Research, and Its Safety Assurance
  • The LMO Consolidated Public Notification contains the standard and procedure of permitting and reporting the installationㆍoperation of LMO research facilities, the standard of installing and operating the research facilities
       necessary for the safety management of LMO research facilities. The research facilities that develop or use LMOs are classified into four levels in terms of safety management (Enforcement Decree of the LMO Act
       [asterisk 1]) and their report or permission should be done for each level.
  • Classification and procedures of the safety management level of LMO research facilities
    Level Target Reporting/Permission
    Level 1 Facilities that develop or conduct experiments using LMO that is known to not cause diseases among healthy adults and LMO that is known to not cause risk to the environment Reporting
    Level 2 Facilities that develop or conduct experiments using LMO that might cause disease among humans, which is easily curable, and LMO that, even if discharged into the environment, might cause minor and easily treatable risk Reporting
    Level 3 Facilities that develop or conduct experiments using LMO that might cause disease among humans, which might have severe symptoms but is curable, and LMO that, if discharged into the environment, might cause significant but treatable risk Permission
    Level 4 Facilities that develop or conduct experiments using LMO that might cause disease among humans, which has fatal symptoms and is hardly curable, and LMO that, if discharged into the environment, might cause enormous and hardly treatable risk Permission
    • ※ Report status (Ministry of Education, Science and Technology, as of 2008): Level 1 (866 organizations), Level 2 (334 organization) reported
  • In addition to the regulations on the installationㆍoperation of LMO research facilities, the LMO Consolidated Public Notification handles the LMO safety management for testsㆍresearches in relation to LMO development,ㆍexperiment approval and the report of LMO imports for testㆍresearches.
  • LMO Safety Management for TestㆍResearch